381164-12-1
| p-2433 | pth (73-84) (human) | c54h96n16o19 | 1273.45 | h-ala-asp-val-asn-val-leu-thr-lys-ala-lys-ser-gln-oh | |
| p-2501 | m65, pac1 receptor antagonist m65 | c199h314n62o60s5 | 4695.39 | h-cys-asp-ala-thr-cys-gln-phe-arg-lys-ala-ile-asp-asp-cys-gln-lys-gln-ala-his-his-ser-asn-val-pro-gly-asn-ser-val-phe-lys-glu-cys-met-lys-gln-lys-lys-glu-phe-lys-ala-nh2 (disulfide bonds between cys¹ and cys⁵/cys¹⁴ and cys³²) | |
| p-2502 | maxadilan | c291h466n86o94s6 | 6865.82 | 135374-80-0 | h-cys-asp-ala-thr-cys-gln-phe-arg-lys-ala-ile-asp-asp-cys-gln-lys-gln-ala-his-his-ser-asn-val-leu-gln-thr-ser-val-gln-thr-thr-ala-thr-phe-thr-ser-met-asp-thr-ser-gln-leu-pro-gly-asn-ser-val-phe-lys-glu-cys-met-lys-gln-lys-lys-lys-glu-phe-lys-ala-nh2 (disulfide bonds between cys¹ and cys⁵/cys¹⁴ and cys⁵¹) |
| p-2601 | h-phe-gly-phe-gly-oh | c22h26n4o5 | 426.47 | 59005-83-3 | h-phe-gly-phe-gly-oh |
| p-2602 | h-d-tyr-val-nh2 | c14h21n3o3 | 279.34 | 87237-39-6 | h-d-tyr-val-nh2 |
| p-2603 | h-d-tyr-val-gly-oh | c16h23n3o5 | 337.38 | 86030-52-6 | h-d-tyr-val-gly-oh |
| p-2701 | ac-ala-ala-ser(po3h2)-pro-arg-pna | c28h43n10o12p | 742.68 | 202739-37-5 | ac-ala-ala-ser(po3h2)-pro-arg-pna |
| p-2702 | suc-ala-ala-pro-phe-amc | c34h39n5o9 | 661.71 | 88467-45-2 | suc-ala-ala-pro-phe-amc |
| p-2703 | suc-ala-ala-pro-phe-2,4-difluoroanilide | c30h35f2n5o7 | 615.63 | 381164-12-1 | suc-ala-ala-pro-phe-2,4-difluoroanilide |
| p-2704 | suc-ala-ala-pro-phe-pna | c30h36n6o9 | 624.65 | 70967-97-4 | suc-ala-ala-pro-phe-pna |
展开全文
